134 related articles for article (PubMed ID: 15327527)
1. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T
Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
[TBL] [Abstract][Full Text] [Related]
4. Implication of SOCS-1 gene methylation in acute myeloid leukaemia.
Watanabe D; Naka T; Kishimoto T
Br J Haematol; 2004 Dec; 127(5):608-9. PubMed ID: 15566367
[No Abstract] [Full Text] [Related]
5. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
7. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
[TBL] [Abstract][Full Text] [Related]
8. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
[TBL] [Abstract][Full Text] [Related]
9. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.
Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG
Blood; 2003 Apr; 101(7):2784-8. PubMed ID: 12456503
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M
Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927
[TBL] [Abstract][Full Text] [Related]
11. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
[TBL] [Abstract][Full Text] [Related]
13. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
[TBL] [Abstract][Full Text] [Related]
14. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients.
Fujitake S; Hibi K; Okochi O; Kodera Y; Ito K; Akiyama S; Nakao A
J Gastroenterol; 2004; 39(2):120-4. PubMed ID: 15074307
[TBL] [Abstract][Full Text] [Related]
16. Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma.
Li Z; Metze D; Nashan D; Müller-Tidow C; Serve HL; Poremba C; Luger TA; Böhm M
J Invest Dermatol; 2004 Oct; 123(4):737-45. PubMed ID: 15373779
[TBL] [Abstract][Full Text] [Related]
17. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.
Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
[TBL] [Abstract][Full Text] [Related]
20. How frequent is SOCS1 methylation in acute myeloid leukaemia?
Chim CS; Kwong YL
Br J Haematol; 2004 Dec; 127(5):609-11. PubMed ID: 15566368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
